Sloan Kettering Institute For Cancer Research
Sloan Kettering Institute For Cancer Research
New York, New York, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Active, not recruiting | Phase 1 | 2026-08-12 | NCT06313593 | |
| SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma | Neoplasms by Histologic Type, epithelioid hemangioendothelioma, hemangioendothelioma, hemangioma, neoplasm, vascular cancer | Recruiting | Phase 2 | 2026-05-26 | NCT07104331 |